• Exosome Raises Development Capital

    News

    Exosome Raises Development Capital

    Exosome Diagnostics, Inc has raised $20 million co-led by NGN Capital , (‘NGN’) New York, and Forbion Capital Partners , (‘Forbion’) Naarden, The Netherlands, to further develop and commercialise a series of next-generation body fluid based oncology diagnostics through its proprietary, exosome based technology platform. The transatlantic Company is establishing R&D and service operations in New York and Munich.

    “We believe our exosome based technology offers a new medium for reproducible, highquality extraction of RNA from blood,” stated James McCullough, CEO of Exosome Diagnostics Inc. “Having NGN and Forbion, lead
    this financing round, provides us with the strong global network necessary to accelerate product development and provide a comprehensive molecular companion diagnostic program to pharmaceutical partners.”

    “The exosome technology platform combines great characteristics for cancer diagnostics and patient monitoring and is well positioned to have a major impact on cancer disease management in the future. We are delighted to join this experienced management team and are excited that this new platform will also be developed and rolled out in Europe using the proceeds of this financing round,” said Geert-Jan Mulder, M.D, General Partner
    at Forbion Capital Partners.


    Digital Edition

    Lab Asia 32.1 Feb 2025

    February 2025

    Chromatography Articles - Comparing volumetric and thermal flowmeters for assessing and validating liquid chromatography performance Mass Spectrometry & Spectroscopy Articles - The importa...

    View all digital editions

    Events

    SPS Smart Production Solutions Guangzhou

    Feb 25 2025 Guanghzou, China

    SmartLab Exchange

    Feb 25 2025 Amsterdam, Netherlands

    Nepal Lab

    Feb 27 2025 Kathmandu, Nepal

    PITTCON 2025

    Mar 01 2025 Boston, MA, USA

    IFPAC 2025

    Mar 02 2025 Bethesda, MD, USA

    View all events

    Redirecting you now.
    Labmate Awards Nominations - Open
    The Labmate Awards for Excellence 2025 seek to recognise innovation, quality and achievement wherever it occurs within the laboratory sector. Launching this year the Labmate Awards for Excellence 2025 will have eleven voting categories chosen to reflect the broad range of noteworthy contributions that have been made across our industry in the past 12 months. Nominate your company Now.